AKTX Akari Therapeutics Plc - American Depositary Shares
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 13, 2026
$8,72
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,13rendah 52m
$29,32tinggi 52m
Kapitalisasi Pasar (MRQ)
$1.22T
EPS
$0.00
lencana Anda
Rentang 52M
$0–$29
Peringkat Analis
BUY
Target Harga
$26
P/E
·
ROE
-64.1%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
AKTX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$8.72
Kapitalisasi Pasar (MRQ)
$1.22T
EPS
$0.00
ROE
-64.1%
D/E Utang/Ekuitas
0.0
Rentang 52M
$0–$29
AKTX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 31 Maret 2026 | 1-for-40 | Terbalik |
| 17 Agu 2023 | 1-for-20 | Terbalik |
| 17 Sep. 2015 | 1-for-10 | Terbalik |
| 3 Jan. 2014 | 1-for-5 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$0.002022-12-31 → 2025-12-31
Arus Kas Bebas·2014-12-31 → 2015-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | AKTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/B (MRQ) | 65667.4rata-rata 5T ≈-42364.4 | ≈-42364.4 | 5.2 | Terlalu mahal | |
| EV / EBITDA | -45700.8 | · | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -74704.9rata-rata 5T ≈-19734.5 | ≈-19734.5 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 39676.4 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | AKTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -35.1%rata-rata 5T ≈-85.2% | ≈-85.2% | -81.5% | Tingkat teratas | |
| ROE | -64.1%rata-rata 5T ≈31150.8% | ≈31150.8% | -113.8% | Tingkat teratas | |
| ROIC | -57.5%rata-rata 5T ≈1781.0% | ≈1781.0% | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | AKTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Debt / Equity (Utang / Ekuitas) | 0.0 | · | · | · | |
| Rasio Lancar (MRQ) | 0.6rata-rata 5T ≈1.3 | ≈1.3 | 1.7 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 0.0rata-rata 5T ≈1.1 | ≈1.1 | 1.3 | Likuiditas rendah | |
| Interest Coverage (Cakupan Bunga) | -172.8 | · | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
36.6%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 13, 2026 | $-2.68 | $-1.31 | -105.3% |
| 31 Maret 2026 | Mei 19, 2026 | $-1.57 | $-1.40 | -11.8% |
| 31 Des. 2025 | $0.00 | $-1.53 | 100.0% | |
| 30 Sep. 2025 | $0.00 | $-3.13 | 100.0% | |
| 30 Juni 2025 | $0.00 | $-4.69 | 100.0% | |
| 31 Maret 2021 | $0.00 | $0.00 | — | |
| 31 Maret 2020 | $-2.60 | $0.00 | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $7M | $5M | $10M | $6M | $2M | $1M | |
| SG&A Expense | $9M | $10M | $11M | $14M | $6M | $303.1K | $2M | |
| Operating Expenses | $17M | $22M | $17M | · | $31M | $2M | · | |
| Operating Income | $-17M | $-22M | $-17M | $-23M | $-31M | $-2M | $-4M | |
| Interest Expense | $100.0K | · | · | · | $3M | $5.4K | · | |
| Interest Income | $1.0K | $8.0K | $82.0K | $46.0K | $20.7K | $91 | · | |
| Other Non-op | $-1M | $2M | $-19.0K | $-142.0K | $-15M | $-28.3K | $-14.0K | |
| Pretax Income | $-18M | $-20M | $-10M | $-17.7K | $-45M | $-2M | · | |
| Income Tax | $-1M | · | $0 | · | $0 | $0 | · | |
| Net Income | $-17M | $-20M | $-10M | $-18M | $-45M | $-2M | $-4M | |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | |
| Shares (Basic) | 67,328,128,638 | 23,888,010,485 | 9,788,980,193 | 6,243,462,410 | 852,088,530 | 85,515,588 | 21,075,065 | |
| Shares (Diluted) | 67,328,128,638 | 23,888,010,485 | 9,788,980,193 | 6,243,462,410 | 852,088,530 | 85,515,588 | 21,075,065 | |
| EBITDA | $-17M | $-22M | $-17M | · | $-31M | $-10M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $0 | $4M | $13M | $69M | $3M | $553.7K | |
| Prepaid Expense | $185.0K | $92.0K | $299.0K | $465.0K | $728.1K | $7.8K | · | |
| Other Current Assets | $14.0K | $201.0K | $197.0K | $100.0K | · | · | · | |
| Current Assets | $5M | $3M | $4M | $14M | $70M | $3M | $8M | |
| PP&E (Net) | · | · | · | · | $40.5K | $0 | $0 | |
| PP&E (Gross) | · | · | · | · | · | $67.0K | $10.0K | |
| Goodwill | $8M | $8M | · | · | · | · | · | |
| Intangibles | · | · | $14.0K | $17.0K | $52.5K | $59.4K | · | |
| Total Assets | $48M | $51M | $4M | $14M | $70M | $3M | $8M | |
| Accounts Payable | $9M | $12M | $2M | $947.0K | $4M | $555.5K | · | |
| Accrued Liabilities | $2M | $3M | $2M | $3M | $408.2K | $43.0K | $403.0K | |
| Short-term Debt | $81.0K | $659.0K | · | · | · | · | · | |
| Current Liabilities | $12M | $20M | $5M | · | $21M | $1M | $1M | |
| Deferred Tax | $7M | $8M | · | · | · | · | · | |
| Other Non-current Liabilities | $31.0K | $383.0K | · | · | · | $33.0K | $0 | |
| Total Liabilities | $20M | $28M | $5M | $12M | $21M | $1M | · | |
| Total Debt | $81.0K | $659.0K | · | · | · | · | · | |
| Common Stock | · | $5M | $1M | $745.0K | $18M | $11M | $675.0K | |
| Paid-in Capital | $234M | $213M | · | · | · | · | · | |
| Retained Earnings | $-265M | $-247M | $-227M | $-217M | $-57M | $-11M | $-21M | |
| AOCI | $-782.0K | $-738.0K | $-1M | $-771.0K | $156.5K | $46.1K | $-33.4K | |
| Stockholders' Equity | $28M | $22M | $-229.0K | $2M | $49M | $2M | $400.7K | |
| Liabilities + Equity | $48M | $51M | $4M | $14M | $70M | $3M | $8M | |
| Shares Outstanding | 90,536,879,533 | 53,186,919,523 | 13,234,315,298 | 7,444,917,123 | 1,177,693,383 | 722,345,600 | 40,227,953 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | $14.0K | $4.0K | $4.0K | · | · | · | |
| Stock-based Comp | $3M | $2M | $1M | $735.0K | $1M | $0 | $94.0K | |
| Deferred Tax | $-1M | · | · | · | · | · | · | |
| Restructuring | $-50.0K | $2M | · | · | · | · | · | |
| Other Non-cash | · | $5M | $-8M | · | · | · | · | |
| Operating Cash Flow | $-11M | $-13M | $-16M | $-22M | $-5M | $-1M | $-5M | |
| CapEx | · | · | · | · | $10.6K | $0 | $0 | |
| Investing Cash Flow | · | $382.0K | · | · | $1M | $0 | $0 | |
| Stock Issued | $11M | $12M | $7M | $25M | $75M | $4M | $0 | |
| Net Stock Activity | $11M | $12M | $7M | · | $75M | $0 | · | |
| Financing Cash Flow | $13M | $11M | $7M | $25M | $69M | $4M | $12M | |
| Net Change in Cash | $3M | $-1M | $-9M | $4M | $66M | $3M | $7M | |
| Free Cash Flow | · | · | · | · | $-5M | $-10M | · | |
| Levered FCF | · | · | · | · | $-8M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| ROA | -35.1% | -72.1% | -110.1% | · | -123.7% | -134.8% | · | |
| ROE | -64.1% | -254.8% | 125100.0% | · | -177.9% | -126.4% | · | |
| ROIC | -57.5% | -94.6% | 7338.9% | · | -62.8% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.1 | · | · | 3.3 | 4.7 | · | |
| Quick Ratio | 0.0 | 0.1 | · | · | 3.3 | 4.6 | · | |
| Debt / Equity | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | -172.8 | · | · | · | -10.0 | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.00 | $0.00 | $0.00 | · | $0.04 | $0.09 | · | |
| Cash Flow / Share | $-0.00 | $-0.00 | $-0.00 | · | $-0.01 | $-0.17 | · | |
| Cash / Share | $0.00 | $0.00 | $0.00 | · | $0.06 | $0.11 | · | |
| EPS (TTM) | $0.00 | $0.00 | $0.00 | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-17M | $-20M | $-10M | · | $-45M | $-2M | · | |
| Market Cap | $26.17B | $64.89B | $41.29B | · | $341.53B | $53.41B | · | |
| Enterprise Value | $26.17B | $64.89B | · | · | · | · | · | |
| P/B | 923.6 | 2919.1 | -180310.3 | · | 7010.1 | 11005.7 | · | |
| P / Tangible Book | 1315.0 | 4702.4 | · | · | · | · | · | |
| P / Cash Flow | -2475.9 | -5169.5 | -2512.8 | · | -68779.7 | -5645.4 | · | |
| P / FCF | · | · | · | · | -68633.7 | -5611.6 | · | |
| EV / EBITDA | -1514.6 | -3000.0 | · | · | · | · | · | |
| Earnings Yield | 0.00% | 0.00% | 0.00% | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $1M | $1M | $249.0K | $667.0K | $813.0K | $1M | $143.0K | $3M | $2M | $3M | $-314.0K | $2M | $2M | $1M | $3M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Operating Expenses | · | $16M | · | · | · | $4M | · | · | · | $6M | · | · | · | · | $4M | $4M | |
| Operating Income | $-5M | $-16M | $-3M | $-7M | $-3M | $-4M | $-5M | $-3M | $-7M | $-6M | $-5M | $-3M | $-5M | $-5M | $-4M | $-4M | |
| Interest Expense | · | · | $0 | $100.0K | · | · | · | · | $51.0K | · | · | · | · | · | $0 | $-6.0K | |
| Interest Income | · | · | $0 | $1.0K | · | · | $1.0K | $3.0K | $2.0K | $2.0K | $7.0K | $16.0K | $29.0K | $30.0K | $30.8K | $19.3K | |
| Other Non-op | $-205.0K | $444.0K | $-2M | $-84.0K | $1M | $-180.0K | $2M | $32.0K | $-109.0K | $-2.0K | $27.0K | $-22.0K | $-13.0K | $-11.0K | $866.6K | $11M | |
| Pretax Income | $-5M | $-15M | $-5M | $-7M | $-2M | $-4M | $-4M | $-3M | · | · | · | · | · | · | $-3M | $7M | |
| Income Tax | · | $-859.0K | $85.0K | $-1M | · | · | · | · | · | $0 | · | · | · | · | $0 | $0 | |
| Net Income | $-5M | $-14M | $-5M | $-6M | $-2M | $-4M | $-4M | $-3M | $-8M | $-6M | $-4M | $-3M | $-4M | $1M | $-3M | $7M | |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | |
| Shares (Basic) | 143,317,469,445 | 118,757,013,401 | · | 65,326,236,698 | 62,943,895,665 | 54,588,283,841 | · | 24,386,005,523 | 18,836,478,977 | 13,453,147,979 | · | 10,116,903,598 | 10,115,005,727 | 7,474,546,753 | 1,177,693,383 | · | |
| Shares (Diluted) | 143,317,469,445 | 118,757,013,401 | · | 65,326,236,698 | 62,943,895,665 | 54,588,283,841 | · | 24,386,005,523 | 18,836,478,977 | 13,453,147,979 | · | 10,116,903,598 | 10,115,005,727 | 7,573,542,457 | 1,177,693,383 | · | |
| EBITDA | $-5M | $-16M | · | $-7M | $-3M | $-4M | · | $-3M | $-7M | $-6M | · | · | · | · | $-4M | · |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | $0 | $2M | $3M | $3M | $0 | $2M | $4M | $1M | $4M | · | · | · | $61M | $69M | |
| Prepaid Expense | $532.0K | $731.0K | $185.0K | $349.0K | $447.0K | $627.0K | $92.0K | $396.0K | $805.0K | $1M | $299.0K | · | · | · | $1M | $728.1K | |
| Other Current Assets | $38.0K | $30.0K | $14.0K | $53.0K | $83.0K | $80.0K | $201.0K | $92.0K | $94.0K | $232.0K | $197.0K | · | · | · | · | · | |
| Current Assets | $8M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | $4M | · | · | · | $63M | $70M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $74.8K | $40.5K | |
| Goodwill | · | · | $8M | $8M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $14.0K | · | · | · | $49.0K | $52.5K | |
| Total Assets | $39M | $34M | $48M | $45M | $51M | $51M | $51M | $3M | $5M | $3M | $4M | · | · | · | $63M | $70M | |
| Accounts Payable | $9M | $9M | $9M | $11M | $12M | $13M | $12M | $5M | $5M | $3M | $2M | · | · | · | $625.4K | $4M | |
| Accrued Liabilities | $4M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | · | · | · | $231.9K | $408.2K | |
| Short-term Debt | · | $49.0K | $81.0K | $198.0K | $179.0K | $228.0K | $659.0K | $200.0K | $600.0K | $900.0K | · | · | · | · | · | · | |
| Current Liabilities | $14M | $13M | $12M | $16M | $17M | $21M | $20M | $9M | $9M | $6M | $5M | · | · | · | $17M | $21M | |
| Deferred Tax | $6M | $6M | $7M | $7M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $31.0K | $69.0K | $128.0K | $266.0K | $383.0K | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $20M | $20M | $20M | $23M | $25M | $29M | $28M | · | · | · | $5M | · | · | · | $17M | $21M | |
| Total Debt | · | $49.0K | · | $198.0K | $179.0K | $228.0K | · | $200.0K | $600.0K | $900.0K | · | · | · | · | · | · | |
| Common Stock | $1.0K | · | · | $7M | $7M | $6M | $5M | $2M | $2M | $2M | $1M | · | · | · | $18M | $18M | |
| Paid-in Capital | $244M | $235M | $234M | $224M | $221M | · | $213M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-284M | $-279M | $-265M | $-259M | $-253M | $-251M | $-247M | $-243M | $-241M | $-233M | $-227M | · | · | · | $-60M | $-57M | |
| AOCI | $-695.0K | $-768.0K | $-782.0K | $-1M | $-1M | $-773.0K | $-738.0K | $-926.0K | $-749.0K | $-761.0K | $-1M | · | · | · | $-36.5K | $156.5K | |
| Stockholders' Equity | $19M | $14M | $28M | $23M | $26M | $22M | $22M | $-7M | $-4M | $-4M | $-229.0K | · | · | · | $46M | $49M | |
| Liabilities + Equity | $39M | $34M | $48M | $45M | $51M | $51M | $51M | $3M | $5M | $3M | $4M | · | · | · | $63M | $70M | |
| Shares Outstanding | 140,032,769,533 | 91,567,009,533 | 90,536,879,533 | 65,229,461,523 | 65,229,461,523 | 57,752,981,523 | 53,186,919,523 | 24,289,231,523 | 24,289,232,698 | 15,973,121,298 | 13,234,315,298 | · | · | · | 1,177,693,383 | 1,177,693,383 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $1.0K | $0 | $0 | $13.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | |
| Stock-based Comp | $711.0K | $305.0K | $471.0K | $685.0K | $719.0K | $1M | $1M | $248.0K | $445.0K | $296.0K | $304.0K | $305.0K | $276.0K | $265.0K | $816.8K | $963.8K | |
| Deferred Tax | $0 | $-859.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | $-100.0K | $0 | $100.0K | $-50.0K | $3M | $-3M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $-2M | $-1M | $-5M | $-4M | $-4M | $-2M | $-5M | $-5M | $-7M | $-7M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $42.1K | · | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-42.1K | $-18.8K | |
| Stock Issued | · | · | $5M | $0 | $4M | $1M | $3M | $-133.0K | $7M | $2M | $4M | $0 | $290.0K | $3M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $2M | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $53.0K | $6M | $2M | $3M | $2M | $2M | $-443.0K | $8M | $2M | $4M | $0 | $291.0K | $3M | · | $-3M | |
| Net Change in Cash | $5M | $-2M | $3M | $-227.0K | $129.0K | $-17.0K | $413.0K | $-2M | $3M | $-3M | $-886.0K | $-2M | $-4M | $-2M | $-7M | $-10M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-7M | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.7% | -34.1% | · | -26.6% | -6.8% | -13.8% | · | -7.1% | -188.1% | -16.9% | · | · | · | · | -8.9% | · | |
| ROE | -21.8% | -80.0% | · | -80.0% | -17.3% | -40.7% | · | -16.7% | 553.7% | -26.0% | · | · | · | · | -12.2% | · | |
| ROIC | · | -103.1% | · | -27.7% | · | · | · | · | · | · | · | · | · | · | -8.3% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.6 | 0.4 | · | · | · | · | 3.8 | · | |
| Quick Ratio | 0.6 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.5 | 0.2 | · | · | · | · | 3.7 | · | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | -0.0 | -0.2 | -0.3 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -74.0 | · | · | · | · | -146.1 | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $-0.00 | $-0.00 | $-0.00 | · | · | · | · | $0.04 | · | |
| Cash Flow / Share | · | $0.00 | · | · | · | $0.00 | · | · | · | $-0.00 | · | · | · | · | $-0.01 | · | |
| Cash / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | $0.05 | · | |
| EPS (TTM) | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-31M | $-28M | · | $-16M | $-12M | $-18M | · | $-20M | $-20M | $-17M | · | · | · | · | $-47M | · | |
| Market Cap | $1.43T | $471.57B | · | $65.88B | $76.32B | $71.61B | · | $71.65B | $65.58B | $29.79B | · | · | · | · | $329.75B | · | |
| Enterprise Value | · | $471.57B | · | $65.88B | $76.32B | $71.61B | · | $71.65B | $65.58B | $29.79B | · | · | · | · | · | · | |
| P/B | 77151.7 | 32793.5 | · | 2903.9 | 2980.6 | 3293.2 | · | -10704.1 | -17710.2 | -8384.4 | · | · | · | · | 7113.2 | · | |
| P / Tangible Book | 77151.7 | 32793.5 | · | 4621.0 | 4443.6 | 5378.0 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -189537.8 | · | · | · | -33308.7 | · | · | · | -7366.4 | · | · | · | · | -44318.4 | · | |
| Earnings Yield | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | · | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-17M | $-20M | $-10M | $-18M | $-45M |
| EPS Dilusian | $0.00 | $0.00 | $0.00 | $0.00 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.0 | 0.0 | · | · | · |
| Rasio Lancar | 0.4 | 0.1 | · | · | 3.3 |
| Rasio Cepat | 0.0 | 0.1 | · | · | 3.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | · | · | · | · | $-5M |
Pemilik institusional (13F) 1 pengaju · $6K total · Per tanggal 31 Des. 2025
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
1
Nilai yang dipegang
$6K
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Skyview Financial Group LLC | $5.946 | 20.575 | 100,00% | Saham |
Aktivis & pemilik 5%+ 6 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Samir R. Patel | 4 Maret 2026 | 10,40% | Amandemen | · | SEC |
| Ray Prudo, M.D., RPC Pharma Limited, Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company ×7 pengajuan | 4 Maret 2026 | 0,87% | Amandemen | · | SEC |
| Samir R. Patel (2) ×2 pengajuan | 6 Des. 2024 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 18 Juni 2024 | · | Pengajuan awal | · | SEC |
| Praxis Trustees Limited As trustee of The Sonic Healthcare Holding Company, RPC Pharma Limited, Ray Prudo, M.D. | 18 Okt. 2021 | · | Pengajuan awal | · | SEC |
| RPC Pharma Limited, Ray Prudo, M.D. ×3 pengajuan | 30 Maret 2020 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 24 orang dalam · 9 pejabat · 19 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Abizer Gaslightwala | CEO | 29 Sep. 2026 A | 14.107 | 2 | 0 | $433.060 |
| Rachelle Suzanne Jacques | Chief Executive Officer | 26 April 2024 A | 1.018.027.792 | 0 | 0 | $0 |
| Gur Roshwalb | Chief Executive Officer | 21 Sep. 2015 A | · | 0 | 0 | $0 |
| Kameel D. Farag | Interim CFO | 17 Agu 2026 A | 23.309 | 1 | 0 | $9.898 |
| Torsten Hombeck | CFO | 20 Maret 2025 A | 200 | 0 | 0 | $0 |
| Wendy F Dicicco | Interim CFO | 1 Mei 2024 A | 158.473.915 | 0 | 0 | $0 |
| Dov Elefant | Chief Financial Officer | 21 Sep. 2015 A | · | 0 | 0 | $0 |
| Clive Richardson | COO | 21 Sep. 2015 A | · | 0 | 0 | $0 |
| Robert M Shaw | General Counsel and Secretary | 23 Maret 2016 A | · | 0 | 0 | $0 |
| Samir R. Patel | Direktur | 7 Juli 2026 M | 98.241 | 2 | 0 | $340.262 |
| Sandip I Patel | Direktur | 16 Des. 2025 P | 496.499 | 2 | 0 | $160.851 |
| Ray Prudo, M.D. | Direktur | 16 Des. 2025 P | 2.484.990 | 2 | 0 | $402.127 |
| Robert B Bazemore | Direktur | 16 Des. 2025 P | 44.642 | 2 | 0 | $61.865 |
| James R Neal | Direktur | 16 Des. 2025 P | 36.271 | 2 | 0 | $2.226 |
| Hoyoung Huh | Direktur | 16 Des. 2025 P | 4.695.854 | 2 | 0 | $1.484.780 |
| Mohamed Wa'El Ahmed Hashad | Direktur | 28 Juni 2024 A | · | 0 | 0 | $0 |
| Michael Grissinger | Direktur | 28 Juni 2024 A | · | 0 | 0 | $0 |
| Donald A Williams | Direktur | 28 Juni 2024 A | · | 0 | 0 | $0 |
| David Byrne | Direktur | 29 Juni 2016 A | · | 0 | 0 | $0 |
| Stuart Ungar | Direktur | 29 Juni 2016 A | · | 0 | 0 | $0 |
| James Hill | Direktur | 29 Juni 2016 A | · | 0 | 0 | $0 |
| Mark S Cohen | Direktur | 29 Juni 2016 A | 1.055.600 | 0 | 0 | $0 |
| Donald Allen Williams | Direktur | 29 Juni 2016 A | · | 0 | 0 | $0 |
| Allan Shaw | Direktur | 25 Nov. 2015 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
AKTX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 10 analis
BELI
Target median
$27.00
+209,6%
3 30,0%
Beli Kuat
6 60,0%
Beli
1 10,0%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
3 analis · 2026-10-03Target rata-rata $25.50 +192,4%
← Di bawah semua target
Harga saat ini $8.72
Rendah$19.50
Rata-rata$25.50
Tinggi$30.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 13, 2026